See the DrugPatentWatch profile for calcium
Dihydropyridine (DHP) calcium channel blockers are a class of medications primarily used to treat hypertension (high blood pressure) and certain types of angina (chest pain) [1]. They work by relaxing and widening blood vessels, which lowers blood pressure and improves blood flow [2].
How do Dihydropyridine calcium channel blockers work?
These drugs target L-type calcium channels, which are prevalent in vascular smooth muscle cells [3]. By blocking these channels, DHPs prevent calcium ions from entering the cells. Calcium influx is essential for muscle contraction; therefore, blocking it leads to the relaxation of vascular smooth muscle. This vasodilation reduces peripheral resistance, thereby decreasing blood pressure [2][4]. Some DHPs also have a similar effect on the coronary arteries, which can improve blood flow to the heart muscle and relieve angina [2].
What are the common types of Dihydropyridine calcium channel blockers?
Commonly prescribed DHP calcium channel blockers include amlodipine, nifedipine, felodipine, and nicardipine [1][4]. These medications are available in various formulations, including immediate-release and extended-release versions, to manage different patient needs [4].
When might a doctor prescribe a DHP calcium channel blocker?
Doctors prescribe DHP calcium channel blockers for conditions such as essential hypertension, including those that are difficult to control with other medications [2][4]. They are also used to manage stable angina and vasospastic angina (Prinzmetal's angina) [1][4].
What are the potential side effects of DHP calcium channel blockers?
The most common side effects are related to vasodilation and can include peripheral edema (swelling in the ankles and feet), flushing, headache, and dizziness [1][2]. Some individuals might experience reflex tachycardia, where the heart rate increases in response to the drop in blood pressure [2]. Less common side effects can include gastrointestinal upset and fatigue [1].
How do DHP calcium channel blockers compare to other blood pressure medications?
Compared to other classes of antihypertensives like ACE inhibitors or ARBs, DHPs are particularly effective at lowering blood pressure through vasodilation. They are often used as monotherapy or in combination with other drug classes to achieve target blood pressure goals [4]. For example, amlodipine is frequently used in combination with ACE inhibitors or ARBs for synergistic blood pressure lowering [2].
What is the patent status of DHP calcium channel blockers?
Many of the first-generation DHP calcium channel blockers, such as nifedipine and felodipine, have had their patents expire years ago, making them available as generics [5]. Newer formulations or combination products involving DHPs may still hold active patents. DrugPatentWatch.com provides detailed information on patent expirations and exclusivity for pharmaceuticals [5].
When does patent exclusivity typically end for DHP calcium channel blockers?
The patent exclusivity for many older DHP calcium channel blockers has long expired, allowing for the widespread availability of generic versions. However, for newer drugs or specific formulations, patent terms vary and can be extended through various regulatory mechanisms. Information on specific drug patent expirations can be found on sites like DrugPatentWatch.com [5].